JMDC Inc
TSE:4483
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 577
4 820
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
JMDC Inc
Cash & Cash Equivalents
JMDC Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
JMDC Inc
TSE:4483
|
Cash & Cash Equivalents
ÂĄ27.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
||
M3 Inc
TSE:2413
|
Cash & Cash Equivalents
ÂĄ57m
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
-43%
|
||
EM Systems Co Ltd
TSE:4820
|
Cash & Cash Equivalents
ÂĄ9.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
||
S
|
Software Service Inc
TSE:3733
|
Cash & Cash Equivalents
ÂĄ14B
|
CAGR 3-Years
24%
|
CAGR 5-Years
4%
|
CAGR 10-Years
17%
|
|
Medley Inc
TSE:4480
|
Cash & Cash Equivalents
ÂĄ15.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
||
e
|
eWeLL Co Ltd
TSE:5038
|
Cash & Cash Equivalents
ÂĄ1.4B
|
CAGR 3-Years
63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
JMDC Inc
Glance View
JMDC, Inc. engages in the provision of medical database and digital solutions to the healthcare sector. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 960 full-time employees. The company went IPO on 2019-12-16. The firm operates in three business segments. The Health Big Data segment is engaged in the provision of receipt data analysis and health promotion solutions, and personal health information platforms, the build, management and analysis of medical databases such as receipt data and medical examination data, the build and sale of drug databases, and the development and provision of systems using drug databases for medical institutions. The Telemedicine segment is engaged in the provision of remote image diagnosis matching services, and infrastructure systems for remote image diagnosis. The Dispensing Pharmacy Support segment is engaged in the development and provision of business systems and electronic medication record for dispensing pharmacies, as well as the operation of dispensing pharmacies.
See Also
What is JMDC Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
27.5B
JPY
Based on the financial report for Sep 30, 2024, JMDC Inc's Cash & Cash Equivalents amounts to 27.5B JPY.
What is JMDC Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
50%
Over the last year, the Cash & Cash Equivalents growth was 28%. The average annual Cash & Cash Equivalents growth rates for JMDC Inc have been 21% over the past three years , 50% over the past five years .